1. Report of A WHO Study Group;Assessment of Fracture Risk and Its Application to screening for Postmenopausal Osteoporosis,1994
2. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases: the official Journal of the National Kidney Foundation;Coresh;Comparative Study Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.,2003
3. Romosozumab Treatment in Postmenopausal Women with Osteoporosis. The New England journal of medicine;Cosman;Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t,2016
4. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. The New England journal of medicine. Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Aug 20 2009;361(8):756–65. (Epub 2009/08/13).
5. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension;Cummings;Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research. Randomized Controlled Trial Research Support, Non-U.S. Gov’t,2018